Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Net Margin (2023 - 2026)

Camp4 Therapeutics' Net Margin history spans 3 years, with the latest figure at 3467.24% for Q4 2025.

  • On a quarterly basis, Net Margin fell 143058.0% to 3467.24% in Q4 2025 year-over-year; TTM through Dec 2025 was 1440.28%, a 648518.0% increase, with the full-year FY2025 number at 1445.77%, up 649764.0% from a year prior.
  • Net Margin hit 3467.24% in Q4 2025 for Camp4 Therapeutics, down from 1663.9% in the prior quarter.
  • Over the last five years, Net Margin for CAMP hit a ceiling of 840.01% in Q2 2025 and a floor of 3467.24% in Q4 2025.
  • Historically, Net Margin has averaged 2134.63% across 3 years, with a median of 1850.28% in 2025.
  • The widest YoY moves for Net Margin: up -143058bps in 2025, down -143058bps in 2025.
  • Tracing CAMP's Net Margin over 3 years: stood at 3341.71% in 2023, then skyrocketed by 39bps to 2036.66% in 2024, then crashed by -70bps to 3467.24% in 2025.
  • Business Quant data shows Net Margin for CAMP at 3467.24% in Q4 2025, 1663.9% in Q3 2025, and 840.01% in Q2 2025.